A previous study showed that the overexpression of HLA-G molecules on the surface of tumour cells affects tumour-specific T cell immunity, and upregulate the expression of ILT2 on tumour-infiltrating CD8+ T cells in the cancer microenvironment (10). The gene discussed is LILRB1; the disease is cancer.